Ekso Bionics Holdings, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Ekso Bionics is asking stockholders to approve a reverse stock split, an amendment to its equity incentive plan, and the issuance of shares upon exercise of a warrant at its upcoming annual meeting.
NASDAQ
DEFA14A: Ekso Bionics Issues Supplement to Proxy Statement to Correct Year Reference for Director Elections
Ekso Bionics has released a supplement to its definitive proxy statement to correct the year reference for the term of directors elected at the upcoming annual meeting.
NASDAQ
Ekso Bionics Holdings, Inc. has filed a definitive proxy statement with the SEC, signaling upcoming shareholder actions.
NASDAQ
DEF 14A: Ekso Bionics Seeks Stockholder Approval for Equity Incentive Plan Extension and Board Elections
Ekso Bionics is holding its 2024 Annual Meeting of Stockholders on June 6, 2024, to vote on key proposals including the election of directors, extension of the equity incentive plan, and executive compensation.